Financhill
Back

Protara Therapeutics 10K Form

Buy
57

TARA
Protara Therapeutics

Last Price:
2.60
Seasonality Move:
31.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TARA News And Ratings

See the #1 stock for the next 7 days that we like better than TARA

TARA Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-7.74M
Price / Cash Flow: 0
Annual Sales: $4.46
Price / Book: 0.58

Profitability

EPS (TTM): -3.19000
Net Income (TTM): $-40.69M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Protara Therapeutics Earnings Forecast

Key Protara Therapeutics Financial Ratios

  • The Interest Expense is -1.72% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Protara Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TARA
CUSIP: 74365U
Website: protaratx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TARA Technical Analysis vs Fundamental Analysis

Buy
57
Protara Therapeutics (TARA) is a Buy

Is Protara Therapeutics a Buy or a Sell?